Australia markets open in 3 hours 47 minutes

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
183.11+2.67 (+1.48%)
At close: 04:00PM EDT
188.00 +4.89 (+2.67%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 43.31B
Enterprise value 37.24B
Trailing P/E 3.51
Forward P/E 5.18
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.94
Price/book (mrq)2.65
Enterprise value/revenue 1.60
Enterprise value/EBITDA 2.01

Trading information

Stock price history

Beta (5Y monthly) -0.08
52-week change 3-59.06%
S&P500 52-week change 3-6.48%
52-week high 3464.00
52-week low 3117.08
50-day moving average 3155.31
200-day moving average 3191.50

Share statistics

Avg vol (3-month) 31.15M
Avg vol (10-day) 3924.64k
Shares outstanding 5243.02M
Implied shares outstanding 6N/A
Float 889.12M
% held by insiders 162.87%
% held by institutions 114.98%
Shares short (14 July 2022) 42.09M
Short ratio (14 July 2022) 41.59
Short % of float (14 July 2022) 4N/A
Short % of shares outstanding (14 July 2022) 40.86%
Shares short (prior month 14 June 2022) 41.93M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 316 June 2022
Ex-dividend date 401 June 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 55.20%
Operating margin (ttm)75.98%

Management effectiveness

Return on assets (ttm)90.32%
Return on equity (ttm)139.59%

Income statement

Revenue (ttm)23.3B
Revenue per share (ttm)95.37
Quarterly revenue growth (yoy)211.20%
Gross profit (ttm)16.07B
EBITDA 17.77B
Net income avi to common (ttm)12.86B
Diluted EPS (ttm)50.99
Quarterly earnings growth (yoy)227.90%

Balance sheet

Total cash (mrq)6.17B
Total cash per share (mrq)25.37
Total debt (mrq)186M
Total debt/equity (mrq)1.17
Current ratio (mrq)5.05
Book value per share (mrq)65.47

Cash flow statement

Operating cash flow (ttm)5.25B
Levered free cash flow (ttm)2.93B